Novel platelet products under development for the treatment of thrombocytopenia or acute hemorrhage

Transfusion and Apheresis Science

Volumn 58, Issue 1, 2019, Pages 7-11

  Michael Fitzpatrick, G ^a  

^a Cellphire Inc   (United States)

Author keywords

Bioreactor; Cryopreserved platelets; DMSO; Ex vivo platelet production; Freeze Dried platelets; Frozen platelets; Lyophilized platelets; Paraformaldehyde; Trehalose

Indexed keywords

PARAFORMALDEHYDE; THROMBOCYTE CONCENTRATE; TREHALOSE;

BLEEDING; FREEZE DRYING; HUMAN; NONHUMAN; REVIEW; ROOM TEMPERATURE; STEM CELL; THROMBOCYTE; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; CYTOLOGY; METABOLISM;

BLOOD PLATELETS; HEMORRHAGE; HUMANS; THROMBOCYTOPENIA;

EID: 85060845357     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2018.12.010     Document Type: Review

References (53)

1. Cardenas, J.C., Zhang, X., Fox, E.E., et al. Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial. Blood Adv 2:July (14) (2018), 1696–1704, 10.1182/bloodadvances.2018017699.
2. Saber A: Ancient Egyptian surgical heritage. J Invest Surg 23 (2010), 327–334.
3. Apostolakis, E., Apostalaki, G., Apostolaki, M., et al. The reported thoracic injuries in Homer's Iliad. J Cardiothoracic Surg, 5, 2010, 114.
4. Kendrick, D.B., Blood program in World War II. 1964, Office of the Surgeon General, Department of the Army, Washington DC Chapter I Transfusion Before World War I.
5. Stansbury, L.G., Hess, J., Blood transfusion in World War I: the roles of Lawrence Bruce Robertson and Oswald Hope Robertson in the "most important medical advance of the war". Transfus Med Rev 23:July (3) (2009), 232–236.
6. Allan, T., Gordon, S., The scalpel, the sword: the story of doctor norman bethune. 1952, McClelland and Stewart, Ontario Canada.
7. Kendrick, D.B., Blood Program in World War II. 1964, Office of the Surgeon General, Department of the Army, Washington DC Chapter XIX, General Considerations of Shock Therapy.
8. Kendrick, D.B., Blood Program in World War II. 1964, Office of the Surgeon General, Department of the Army, Washington DC Chapter XX The Blood, Plasma, and Related Program in the Korean War.
9. Emergency War Surgery, US Army Medical Department Center and School Fort Sam Houston. second edition, 1988, Texas Office of The Surgeon General United States Army Falls Church, Virginia.
10. Emergency War Surgery, US Army Medical Department Center and School Fort Sam Houston. third edition, 2004, Texas Office of The Surgeon General United States Army Falls Church, Virginia.
11. Emergency War Surgery, US Army Medical Department Center and School Fort Sam Houston. fourth edition, 2013, Texas Office of The Surgeon General United States Army Falls Church, Virginia.
12. National Academies of Sciences, Engineering, and Medicine, A national trauma care system: Integrating military and civilian trauma systems to achieve zero preventable deaths after injury. 2016, The National Academies Press, Washington, DC, 10.17226/23511.
13. Holcomb, J.B., del Junco, D.J., Fox, E.E., et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 148:2 (2013), 127–136, 10.1001/2013.jamasurg.387.
14. Holcomb, J.B., Tilley, B.C., Baraniuk, S., et al. Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe TraumaThe PROPPR Randomized Clinical Trial. JAMA 313:5 (2015), 471–482, 10.1001/jama.2015.12.
15. Maher, P., Utarnachitt, R., Louzon, M.J., et al. Logistical concerns for prehospital blood product use by air medical services. Air Med J, 36, 2017, 263e267.
16. Brown, J.B., Sperry, J.L., Fombona, A., et al. Pretrauma center red blood cell transfusion is associated with improved early outcomes in air medical trauma patients. J Am Coll Surg, 220, 2015, 797e808.
17. Sperry, J.L., Guyette, F.X., Brown, J.B., et al. Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock; July 26, 2018. N Engl J Med(379), 2018, 315–326, 10.1056/NEJMoa1802345.
18. Ramirez, R.J., Spinella, P.C., Bochcchio, G.V., Tranexamic acid update in trauma. Crit Care Clin 33:January (1) (2017), 85–99, 10.1016/j.ccc.2016.08.004.
19. Huang, B., Xu, Q., r, Ye, Xu, J., Influence of tranexamic acid on cerebral hemorrhage: a meta-analysis of randomized controlled trials. Clin Neurol Neurosurg 171:June (2018), 174–178, 10.1016/j.clineuro.2018.06.017.
20. Women trial Collaborators, Shakur, H., Roberts, I., Fawole, B., et al. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 389:May–June (10084) (2017), 2105–2116.
21. Desborough, M.J., Smethurst, P.A., Estcourt, L.J., Stanworth, S.J., Alternatives to allogeneic platelet transfusion. B r J Haematol 175:November (3) (2016), 381–392, 10.1111/bjh.14338 Epub 2016 Sep 21.
22. Blajchman, M.A., Substitutes and alternatives to platelet transfusions in thrombocytopenic patients. J Thromb Hemost 1:July (7) (2003), 1637–1641, 10.1046/j.1538-7836.2003.00332.x.
23. Read, M.S., Reddick, R.L., Bode, A.P., Bellinger, D.A., Nichols, T.C., Taylor, K., et al. Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusion. Proc Natl Acad Sci U S A. 92:2 (1995), 397–401.
24. Bode, A.P., Read, M.S., Reddick, R.L., Activation and adherence of lyophilized human platelets on canine vessel strips in the Baumgartner perfusion chamber. J Lab Clin Med 133:2 (1999), 200–211.
25. Bode, A.P., Read, M.S., Lyophilized platelets: continued development. Transfus Sci 22:1-2 (2000), 99–105.
26. Valeri, C.R., Macgregor, H., Barnard, M.R., Summaria, L., Michelson, A.D., Ragno, G., In vitro testing of fresh and lyophilized reconstituted human and baboon platelets. Transfusion 44:10 (2004), 1505–1512.
27. Fischer, T.H., Wolberg, A.S., Bode, A.P., Nichols, T.C., The interaction of factor VIIa with rehydrated, lyophilized platelets. Platelets 19:3 (2008), 182–191.
28. Fischer, T.H., Bode, A.P., Parker, B.R., Russell, K.E., Bender, D.E., Ramer, J.K., et al. Primary and secondary hemostatic functionalities of rehydrated, lyophilized platelets. Transfusion 46:11 (2006), 1943–1950.
29. Hawksworth, J.S., Elster, E.A., Fryer, D., Sheppard, F., Morthole, V., Krishnamurthy, G., et al. Evaluation of lyophilized platelets as an infusible hemostatic agent in experimental non-compressible hemorrhage in swine. J Thromb Haemost 7:10 (2009), 1663–1671.
30. Wolkers, W.F., Walker, N.J., Tablin, F., Crowe, J.H., Human platelets loaded with trehalose survive freeze-drying. Cryobiology 42:2 (2001), 79–87.
31. Crowe, J.H., Anhydrobiosis: an unsolved problem. Plant Cell Environ 37:7 (2014), 1491–1493.
32. Joshi, N.V., Raftis, J.B., Lucking, A.J., Hunter, A.H., Millar, M., Fitzpatrick, M., et al. Lyophilised reconstituted human platelets increase thrombus formation in a clinical ex vivo model of deep arterial. Thromb. Haemost. 107:1 (2012), 176–182.
33. Fitzpatrick, G.M., Cliff, R., Tandon, N., Thrombosomes: a platelet-derived hemostatic agent for control of noncompressible hemorrhage. Transfusion, 53(Suppl 1), 2013 100S-6S.
34. Fitzpatrick, G.M., Vibhudatta, A., H. A J. D, Trehalose stabilized freeze dried human platelets, thrombosomes, reduce blood loss in thrombocytopenic rabbit ear bleed model by as much as 89.5%. Vox Sang, 99(Suppl 1 P-0452), 2010, 261.
35. Getz, T.M., Bode, A.P., Hale, A.S., Stanton, M., Johnson, M., Fitzpatrick, G.M., Safety evaluation of lyophilized canine platelets in a model of coronary artery bypass graft (CABG). Transfusion, 57(Supplement S3), 2017, 21A.
36. Barroso, J., Osborne, B., Teramura, G., Pellham, E., Fitzpatrick, M., Biehl, R., et al. Safety evaluation of a lyophilized platelet-derived hemostatic product. Transfusion 12 (2018), 2969–2977.
37. Rybak, M.E., Renzulli, L.A., A liposome based platelet substitute, the plateletsome, with hemostatic efficacy. Biomater Artif Cells Immobilization Biotechnol, 21(2), 1993, 101e18.
38. Rybak, M.E., A platelet substitute-the plateletsome to be used in transfusion therapy. in: report by university of massachusetts medical center. Fort Detrick., 1989, US Army Medical Research and Development Command, Frederick, Maryland, 1e41 Contract No. DAMD17-87-C-7172.
39. Levi, M., Friederich, P.W., Middleton, S., de Groot, P.G., Wu, Y.P., Harris, R., et al. Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits. Nat Med, 5(1), 1999 107e11. [52] Yen RC, Ho TW, Blajchman MA.
40. Ravikumar, M., Modery, C.L., Wong, T.L., Sen Gupta, A., Peptide-decorated liposomes promote arrest and aggregation of activated platelets under flow on vascular injury relevant protein surfaces in vitro. Biomacromolecules, 13(5), 2012 1495e502.
41. Takeoka, S., Teramura, Y., Okamura, Y., Tsuchida, E., Handa, M., Ikeda, Y., Rolling properties of rGPIbalpha-conjugated phospholipid vesicles with different membrane flexibilities on vWf surface under flow conditions. BiochemBiophys Res Commun, 296(3), 2002, 765e70.
42. Takeoka, S., Okamura, Y., Teramura, Y., Watanabe, N., Suzuki, H., Tsuchida, E., et al. Function of fibrinogen gamma-chain dodecapeptide-conjugated latex beads under flow. Biochem Biophys Res Commun, 312(3), 2003, 773e9.
43. Okamura, Y., Fujie, T., Maruyama, H., Handa, M., Ikeda, Y., Takeoka, S., Prolonged hemostatic ability of polyethylene glycol-modified polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide. Transfusion, 47(7), 2007 1254e62.
44. Nishiya, T., Kainoh, M., Murata, M., Handa, M., Ikeda, Y., Reconstitution of adhesive properties of human platelets in liposomes carrying both recombinant glycoproteins Ia/IIa and Ib alpha under flow conditions: specific synergy of receptor-ligand interactions. Blood, 100(1), 2002, 136e42.
45. Okamura, Y., Takeoka, S., Eto, K., Maekawa, I., Fujie, T., Maruyama, H., et al. Development of fibrinogen gamma-chain peptide-coated, adenosine diphosphate-encapsulated liposomes as a synthetic platelet substitute. J Thromb Haemost, 7(3), 2009, 470e7.
46. Okamura, Y., Takeoka, S., Teramura, Y., Maruyama, H., Tsuchida, E., Handa, M., et al. Hemostatic effects of fibrinogen gamma-chain dodecapeptide-conjugated polymerized albumin particles in vitro and in vivo. Transfusion, 45(7), 2005, 1221e8.
47. Bertram, J.P., Williams, C.A., Robinson, R., Segal, S.S., Flynn, N.T., Lavik, E.B., Intravenous hemostat: nanotechnology to halt bleeding. Sci Transl Med, 1(11), 2009, 11e22.
48. Lasky, L.C., Sullenbarger, B., Manipulation of oxygenation and flow-induced shear stress can increase the in vitro yield of platelets from cord blood. Tissue Eng Part C Methods 17:11 (2011), 1081–1088 [PubMed: 21877917].
49. Takayama, N., Nishimura, S., Nakamura, S., Shimizu, T., Ohnishi, R., Endo, H., et al. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 207:13 (2010), 2817–2830 [PubMed: 21098095].
50. Avanzi, M.P., Oluwadara, O.E., Cushing, M.M., Mitchell, M.L., Fischer, S., Mitchell, W.B., A novel bioreactor and culture method drives high yields of platelets from stem cells. Transfusion 56:1 (2016), 170–178 [PubMed: 26467770].
51. Kandace, G., Lambert, M.P., Poncz, M., Current status of blood ‘pharming’: megakaryocyte transfusions as a source of platelets. Curr Opin Hematol 24:November (2017), 565–571, 10.1097/MOH.0000000000000378.
52. Thon, J.N., Dykstra, B.J., Beaulieu, L.M., Platelet bioreactor: accelerated evolution of design and manufacture. Platelets 28:July (5) (2017), 472–477, 10.1080/09537104.2016.1265922.
53. Ito, Y., Nakamura, S., Sugimoto, N., Turbulence activates platelet biogenesis to enable clinical scale ex vivo production. Cell 174:July (3) (2018), 636–648, 10.1016/j.cell.2018.06.011.